Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05134480 · ClinicalTrials.gov registry record · NA
Impact of Donor Diabetes on DMEK Success and Endothelial Cell Loss
A NA study, sponsored by Case Western Reserve University.
- Completed
- Registry status
- NA
- Development phase
- 1,097
- Enrollment target
NCT05134480 is a NA study that has completed, run by Case Western Reserve University. The registered enrollment target is 1,097 participants.
The verdict
NCT05134480, a NA study, has completed, sponsored by Case Western Reserve University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,097 participants
- Enrollment target
Study Summary
This double-masked multi-center trial will evaluate the association of diabetes in the cornea donor with transplant success and loss of endothelial cells through 1 year following Descemet membrane endothelial keratoplasty (DMEK). Study eyes are assigned to receive either a cornea from a donor without diabetes or a cornea from a donor with diabetes.
Interventions
- PROCEDURE Descemet membrane endothelial keratoplasty
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,097 participants |
| Start Date | 2022-01-21 |
| Est. Completion | 2025-09-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05134480
The ClinicalTrials.gov registry entry for NCT05134480 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,097 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Western Reserve University, which has 141 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Descemet membrane endothelial keratoplasty is the first listed.
NCT05134480 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05134480 about?
NCT05134480 is a clinical study titled "Impact of Donor Diabetes on DMEK Success and Endothelial Cell Loss". This double-masked multi-center trial will evaluate the association of diabetes in the cornea donor with transplant success and loss of endothelial cells through 1 year following Descemet membrane endothelial keratoplasty (DMEK). Study eyes are assigned to receive either a cornea from a donor withou...
What is the current status of trial NCT05134480?
This trial is currently completed. It is a NA study. The enrollment target is 1,097 participants. The study started on 2022-01-21. Estimated completion is 2025-09-15.
What interventions are being tested in trial NCT05134480?
The interventions under investigation include: Descemet membrane endothelial keratoplasty (PROCEDURE).
Who is sponsoring clinical trial NCT05134480?
This trial is sponsored by Case Western Reserve University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.